A. Juretić - Concepedia

Author

A. Juretić

University Hospital Centre Zagreb

Also Known As

A Juretic, A Juretić, A. JURETIĆ, A. Juretic, A. Juretić, ANTONIO JURETIC, Antonio Juretic, Antonio Juretić

Publications

353

Citations

H-Index

Concepts

All Affiliations

University Hospital Centre Zagreb University of Basel Roche (Switzerland)Max Planck Institute for Biology

About

A. Juretić is an author at University Hospital Centre Zagreb specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	286
2	Immunology	9	9	263
3	Allergy	5	5	142
4	Cell Biology	5	5	131
5	Health Sciences	1	1	33

A. Juretić

Publications

305

Citations

H-Index

Page 1

	Year	Citations
Glutamine requirements in the generation of lymphokine-activated killer cells A. Juretić, Giulio C. Spagnoli, Heidi Hörig, Clinical Nutrition Autoimmune DiseaseGlutamine RequirementsImmunologyImmunologic MechanismAutoimmunity	1994	46
Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study Rajko Kavalar, Boris Šarčević, G.C. Spagnoli, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Immunohistochemical StudyBreast OncologyMedicineImmunologyTumour Differentiation	2001	43
On the Relative Roles of Interleukin-2 and Interleukin-10 in the Generation of Lymphokine-Activated Killer Cell Activity Giulio C. Spagnoli, A. Juretić, Elke Schultz‐Thater, Cellular Immunology InflammationCytokineRelative RolesAllergyAutoimmune Disease	1993	36
Alterations in Lymphocyte Phenotype of Infected Preterm Newborns Emilja Juretić, A. Juretić, Branka Užarević, Neonatology Maternal ImmunizationImmunohematologyInfected Preterm NewbornsAllergyMemory Helper T	2001	33
Selective in vivo inhibition of T cell activation by class II MHC-binding peptides administered in soluble form. Sylviane Muller, Luciano Adorini, A. Juretić, The Journal of Immunology ImmunologyImmunodominanceImmunologic MechanismAntigen ProcessingVivo Priming	1990	28
Class I restricted interaction between suppressor and cytolytic cells in the response to minor histocompatibility antigens. H. G. Rammensee, A. Juretić, Z A Nagy, The Journal of Immunology HistocompatibilityImmunologyPathologyImmunodominanceClass Ii Loci	1984	23
Combined modality therapy of non-small cell lung cancers A. Juretić, Hrvoje Šobat Annals of Oncology Modality TherapyMedicineBronchial NeoplasmCombined Modality TreatmentPulmonary Blastoma	1999	23
Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice. A. Juretić, B Malenica, Emilja Juretić, The Journal of Immunology HistocompatibilityForeign E MoleculeHla ImmunogeneticsImmunologyAntigen Processing	1985	22
Differential Effects of Inteleukin-2 and CD3 Triggering on Cytokine Gene Transcription and Secretion in Cultured Tumor Infiltrating Lymphocytes Luis Filgueira, Markus Zuber, A. Juretić, Cellular Immunology Differential EffectsCancer ImmunosurveillanceImmunologyCd3 TriggeringImmunologic Mechanism	1993	22
Ureteral metastasis of occult breast cancer Tvrtko Hudolin, Nenad Nola, Ivan Milas, The Breast	2004	19

Page 1